|
CA163200A
(en)
|
1915-02-20 |
1915-06-15 |
William James Davidson |
Ash sifting shovel
|
|
US3270960A
(en)
|
1964-09-11 |
1966-09-06 |
Sperry Rand Corp |
Fluid sensor
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US4747825A
(en)
|
1984-06-29 |
1988-05-31 |
Ferring Laboratories, Inc. |
Apparatus and methodology for pulsed administration of growth promoting agents
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4948592A
(en)
|
1986-05-09 |
1990-08-14 |
Alza Corporation |
Pulsed drug delivery
|
|
US4723958A
(en)
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US4965251A
(en)
|
1987-04-03 |
1990-10-23 |
The Board Of Regents Of The University Of Washington |
Pulse treatment of hemoglobinopathies with erythropoietin
|
|
DE10399032I1
(de)
|
1987-08-28 |
2004-01-29 |
Health Research Inc |
Rekombinante Viren.
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
FR2658432B1
(fr)
|
1990-02-22 |
1994-07-01 |
Medgenix Group Sa |
Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
MY109299A
(en)
|
1990-08-15 |
1996-12-31 |
Virogenetics Corp |
Recombinant pox virus encoding flaviviral structural proteins
|
|
JP4236698B2
(ja)
|
1990-11-26 |
2009-03-11 |
ジェネティックス インスティチュート，リミテッド ライアビリティ カンパニー |
宿主細胞でのｐａｃｅの発現およびその使用法
|
|
US5270181A
(en)
|
1991-02-06 |
1993-12-14 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
CN1091138A
(zh)
|
1992-08-27 |
1994-08-24 |
迪金研究有限公司 |
疫苗
|
|
US5403590A
(en)
|
1992-12-21 |
1995-04-04 |
New England Deaconess Hospital Corporation |
Method of pulsatile drug infusion
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
|
US5587384A
(en)
|
1994-02-04 |
1996-12-24 |
The Johns Hopkins University |
Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
AU4594996A
(en)
|
1994-11-30 |
1996-06-19 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
SI0833934T2
(sl)
|
1995-06-15 |
2013-04-30 |
Crucell Holland B.V. |
Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
|
|
US5622856A
(en)
|
1995-08-03 |
1997-04-22 |
Avigen |
High efficiency helper system for AAV vector production
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US6004797A
(en)
|
1995-11-09 |
1999-12-21 |
Avigen, Inc. |
Adenovirus helper-free recombinant AAV Virion production
|
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
|
US6048551A
(en)
|
1997-03-27 |
2000-04-11 |
Hilfinger; John M. |
Microsphere encapsulation of gene transfer vectors
|
|
US6365185B1
(en)
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
AU5756100A
(en)
*
|
1999-06-21 |
2001-01-09 |
Genetics Institute Inc. |
Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
|
|
CA2404763A1
(en)
*
|
1999-11-11 |
2001-05-17 |
Raj K. Puri |
Mutated il-13 molecules and their uses
|
|
EP2990420B1
(en)
*
|
2000-05-26 |
2016-12-21 |
Immunex Corporation |
Use of interleukin-4 receptor antibodies and compositions thereof
|
|
US7785580B2
(en)
*
|
2003-08-29 |
2010-08-31 |
Aerovance, Inc. |
Modified IL-4 mutein receptor antagonists
|
|
AU2005219837A1
(en)
*
|
2004-02-27 |
2005-09-15 |
Regeneron Pharmaceuticals, Inc. |
IL-4/IL-13 sepecific polypetides and therapeutic uses thereof
|
|
US20050287066A1
(en)
|
2004-06-28 |
2005-12-29 |
Monoace, Inc. |
Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof
|
|
US20110268749A1
(en)
|
2007-07-31 |
2011-11-03 |
The Government of the US as Represented by the Secretary Department of Health and Human Services |
Treatment of cancer via targeting of il-13 receptor-alpha2
|
|
CA2698666A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
EP2050764A1
(en)
*
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
|
US20110256130A1
(en)
*
|
2008-12-01 |
2011-10-20 |
Joshua Robert Schultz |
Methods of treating inflammatory disorders
|
|
US9296785B2
(en)
|
2009-04-17 |
2016-03-29 |
Wake Forest University Health Sciences |
IL-13 receptor binding peptides
|
|
TWI732259B
(zh)
*
|
2010-12-16 |
2021-07-01 |
美商建南德克公司 |
關於th2抑制作用之診斷及治療
|
|
HK1197159A1
(en)
*
|
2011-05-25 |
2015-01-09 |
Intermune, Inc. |
Pirfenidone and anti-fibrotic therapy in selected patients
|
|
EP3194446B1
(en)
|
2014-09-18 |
2022-10-26 |
Cedars-Sinai Medical Center |
Compositions and methods for treating fibrosis
|